Your browser doesn't support javascript.
loading
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies.
Appleman, Leonard J; Beumer, Jan H; Jiang, Yixing; Lin, Yan; Ding, Fei; Puhalla, Shannon; Swartz, Leigh; Owonikoko, Taofeek K; Donald Harvey, R; Stoller, Ronald; Petro, Daniel P; Tawbi, Hussein A; Argiris, Athanassios; Strychor, Sandra; Pouquet, Marie; Kiesel, Brian; Chen, Alice P; Gandara, David; Belani, Chandra P; Chu, Edward; Ramalingam, Suresh S.
Afiliación
  • Appleman LJ; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. applemanlj@upmc.edu.
  • Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. applemanlj@upmc.edu.
  • Jiang Y; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. applemanlj@upmc.edu.
  • Lin Y; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Ding F; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Puhalla S; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Swartz L; Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA.
  • Owonikoko TK; Penn State Hershey Cancer Institute, Hershey, PA, USA.
  • Donald Harvey R; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Stoller R; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Petro DP; UPMC Hillman Cancer Center Biostatistics Facility, Pittsburgh, PA, USA.
  • Tawbi HA; Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.
  • Argiris A; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Strychor S; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Pouquet M; UPMC Hillman Cancer Center Biostatistics Facility, Pittsburgh, PA, USA.
  • Kiesel B; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Chen AP; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Gandara D; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Belani CP; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Chu E; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Ramalingam SS; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Cancer Chemother Pharmacol ; 84(6): 1289-1301, 2019 12.
Article en En | MEDLINE | ID: mdl-31549216
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bencimidazoles / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Antineoplásicos / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Neoplasias Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bencimidazoles / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Antineoplásicos / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Neoplasias Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos